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The spontaneous proliferation of peripheral blood mononuclear cells (PBMCs) is a hallmark of the human T-lymphotropic virus
(HTLV) type-1. Cell proliferation is usually measured using a [3H]thymidine incorporation assay. This study aims to quantify
the spontaneous proliferation of PBMCs using ﬂow cytometry. PBMCs were cultured for 24 to 120 hours in the presence of 5,6-
carboxyﬂuorescein diacetate succinimidyl ester (CFSE). For comparison, PBMCs were also cultured with [3H]thymidine. The
cutoﬀ values for spontaneous proliferation were >0.06 for the division index and >5.8% for the percentage of divided cells. Sixty-
two percent of HTLV-1-infected individuals presented spontaneous proliferation of PBMCs, which was detected in the ﬁrst 24
hours. Moreover, proliferation was detected in CD4+ and CD8+ T-lymphocyte subsets. A positive correlation was found between
the division index and [3H]thymidine incorporation. This method may prove useful to better understand the phenomenon of
spontaneous proliferation of PBMC of patients infected with HTLV-1.
1.Introduction
Human T-lymphotropic virus type 1 (HTLV-1) is the etio-
logic agent of adult T-cell leukemia lymphoma (ATLL) and
HTLV-1-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) and is associated with uveitis and infective
dermatitis in children [1–5]. One of the immunological hall-
marks of HTLV infection is the in vitro spontaneous prolif-
eration of peripheral blood mononuclear cells (PBMCs), as
well as a high production of cytokines such as IFN-γ,T N F - α,
IL-10, and IL-2 [6–11]. HTLV-1 preferentially infects CD4+
T lymphocytes, and the spontaneous proliferation of these
cells sustains viral load, since newly infected cells are mainly
derived by the clonal expansion of infected lymphocytes [7].
There is evidence that both the intensity of spontaneous
proliferation and the proviral load are higher in HAM/TSP
patients when compared to asymptomatic carriers [12–16].
Classically, the intensity of cell proliferation is measured
using a [3H]thymidine incorporation assay, which requires
the handling of carcinogenic and radioactive material.
A proliferation assay based on cell staining with 5,6-
carboxyﬂuorescein succinimidyl ester (CFSE) and ﬂow
cytometry analysis has been described as an alternative
approach [7, 17]. This method has been employed in
a wide range of applications, including the detection of
T-cell responses against autoantigens and the activity of
regulatory T cells [18, 19]. However, the applicability of this
assay in HTLV-1-infected patients has not been established.
This study aims to quantify the spontaneous prolifera-
tion of PBMCs in HTLV-1-infected individuals using ﬂow2 ISRN Oncology
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Figure 1: Evaluation of spontaneous proliferation of PBMC from HTLV-1-infected individuals using ﬂow cytometry. (a) Division index of
cells. (b) Percentage of divided cells. Uninfected (n = 14) and HTLV-1-infected individuals (n = 45). The cutoﬀ values to spontaneous
proliferation were >0.06 for index division of cells and >5.8% for percentage of divided cells (three times the mean of index division of cells
and percentage of divided cells for uninfected PBMC). (c) Correlation between the index division of cells and [3H]thymidine incorporation
(peak cpm/1000). (d) Correlation between the percentage of divided cells and [3H]thymidine incorporation (peak cpm/1000). Diﬀerences
were considered signiﬁcant when P was <0.05 (Mann-Whitney U test). Spearman’s correlation coeﬃcients were used.
cytometry as a means to facilitate the understanding of
the mechanism that trigger this phenomenon in HTLV-1-
infected individuals.
2.MaterialsandMethods
2.1. Patients. Forty-ﬁve HTLV-1-infected individuals from
HTLV-1 Reference Center of Science Development Foun-
dation (Salvador, BA, Brazil) were included in the study.
Serum samples were screened for the presence of HTLV-
1/2 antibodies by using an enzyme-linked immunosorbent
assay (ELISA) (Ab-Capture ELISA test system; Ortho-
Clinical Diagnostics, Inc., Raritan, NJ) and conﬁrmed by
Western blot assay (HTLV Blot 2.4; Genelabs Technologies,
Singapore). Blood samples from 14 healthy individuals from
the Gonc ¸alo Moniz Research Center were used as controls.
Informed consent was obtained from all enrolled patients,
and the institutional research board of the Oswaldo Cruz
Foundation (FIOCRUZ) approved this study.
2.2.MediaandReagents. RPMI1640medium(SigmaChem-
ical Co., St. Louis, Mo) was supplemented with 2mM L-
glutamine(SIGMA),1%nonessentialaminoacids(GIBCO),
1mM sodium pyruvate (SIGMA), 100U/mL penicillin
(SIGMA), 100μg/mL streptomycin (SIGMA), 100μg/mL
HEPES (Invitrogen), and fetal calf serum (10%; Hyclone,
Logan, UT).
2.3. Cells. Peripheral blood mononuclear cells (PBMCs)
from individuals were obtained from heparinized venous
blood samples by density gradient centrifugation usingISRN Oncology 3
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Figure 2: Evaluation of spontaneous proliferation of lymphocyte subsets from HTLV-1-infected individuals using ﬂow cytometry. (a)
Division index of CD4+ T-lymphocytes subset. (b) Division index of CD8+ T-lymphocytes subset. (c) Percentage of divided CD4+ T-
lymphocytes subset. (d) Percentage of divided CD8+ T-lymphocytes subset. Uninfected (n = 06) and HTLV-1-infected individuals (n = 10).
The cutoﬀ values to spontaneous proliferation of CD4+ and CD8+ T-lymphocytes subsets were >0.06 for index division of cells and >5.2%
for percentage of divided cells (three times the mean of index division and % of divided cells for uninfected PBMC).
SepCell (LGC Biotechnology, S˜ ao Paulo, SP, Brazil). All
experiments were performed with freshly isolated PBMC.
2.4. Cell Proliferation Assay. The PBMC of HTLV-1-infected
individuals were cultured in RPMI 1640 culture medium
with 10% AB serum. The PBMC, from healthy individuals
were cultured in RPMI 1640 culture medium in the presence
of 10% AB serum and 1U/mL of IL-2 (Sigma Chemical
Co., St. Louis, Mo, USA). Cells were cultured using 96-
well U-bottom culture plates (Costar, Cambridge, mass) in
triplicate at 37◦Ci na5 %C O 2 humidiﬁed atmosphere for
5 days. The culture medium was changed on the third day.
To evaluate cell proliferation, PBMC, were labeled before
culture with 5,6-carboxyﬂuorescein diacetate succinimidyl
ester (CFSE) (5μM) (Invitrogen, Eugene, USA) according to
the manufacturer’s instructions and maintained in culture
during 24, 48, 72, 96, and 120 hours. Then, cells were
harvested and washed twice in 2mL of phosphate-buﬀered
saline containing 1% bovine serum albumin. After a ﬁnal
wash, cells were ﬁxed in phosphate-buﬀered saline contain-
ing 4% paraformaldehyde. To evaluate the proliferation of
T-lymphocyte subsets, PBMCs were stained with mono-
clonal anti-CD3PE-Cy5 (BD Biosciences), anti-CD4PE (Cal-
tag), and anti-CD8APC (BD Biosciences) antibodies. Then,
cells were ﬁxed in phosphate-buﬀered saline containing
4% paraformaldehyde. Analyses were performed using a4 ISRN Oncology
Table 1: KineticsofspontaneousproliferationofPBMCfromHTLV-1-infectedindividuals usingﬂowcytometryatdiﬀerent times (n = 06).
Measure of Time (hours)
proliferation 24 48 72 96 120
Index division∗ 0.06 ± 0.06 0.05 ± 0.05 0.05 ± 0.06 0.05 ± 0.05 0.06 ± 0.05
% divided cells∗∗ 5.1 ± 5.0 4.5 ± 4.8 4.2 ± 5.4 4.0 ± 4.2 4.3 ± 4.0
Median ± Standard Derivation, Kruskal-Wallis test, ∗P = 0.9; ∗∗P = 1.0.
FACSAria (Becton Dickinson, Mountain View, Calif, Ohio,
USA) and FlowJo software (Ashland, USA). At least 105
events were analyzed per sample. Proliferation intensity was
determined through the percentage of divided cells and the
cell division index (Figure 3). The percentage of divided cells
was considered the percentage of the cells of the original
sample which divided (assuming that no cells died during
the culture), while division index was the average number
of divisions that a cell (that was present in the starting
population) has undergone.
Additionally, cells from 11 HTLV-1-infected individuals
were cultured for 5 days and pulsed overnight with 1μCi
[3H]thymidine (speciﬁc activity, 2 Ci/mmol; ICN, Costa
Mesa, Calif, USA). After this period, the content of the
plate was harvested to determine the [3H]thymidine incor-
poration using a Beta Radiation Counter (β-matrix 9600,
Packard, Meriden, Conn, USA). Results were expressed as
mean counts per minute.
2.5. Statistical Analyses. Data were expressed as percentages,
means, standard deviations, medians, and 25% and 75%
percentiles.GroupswerecomparedusingtheMann-Whitney
test and Kruskal-Wallis test. Correlations were evaluated
by Spearman correlation. A P value of less than 0.05
denoted a statistically signiﬁcant diﬀerence. Graphad Prism
5.0 software was used for all statistical analyses.
3. Results
The cutoﬀ values to deﬁne spontaneous proliferation were
>0.06forthecelldivisionindexand>5.8%forthepercentage
of divided cells, which represents three times the division
index mean and three times the percentage of divided cells in
PBMCs from uninfected controls. Under these criteria, 62%
of HTLV-1-infected individuals presented spontaneous pro-
liferation in PBMCs as measured by the cell division index,
while 47% presented proliferation using the percentage of
divided cells (Figure 1).
Cell proliferation was detected in the ﬁrst 24h and
remained constant over 120h (P = 0.9) (Table 1).
Additionally, using ﬂow cytometry, the proliferation of
both CD4 and CD8 T-lymphocyte subsets could be quan-
tiﬁed. The cutoﬀ values to deﬁne spontaneous proliferation
in CD4+ and CD8+ T-lymphocyte subsets were similar to
those deﬁned in the PBMC quantiﬁcation: >0.06 for the
cell division index of cells and >5.2% for the percentage
of divided cells. Under these criteria, 50% of HTLV-1-
infected individuals presented spontaneous proliferation of
CD4+ T lymphocytes, while 30% presented spontaneous
proliferation of CD8+ Tl y m p h o c y t e s( Figure 2).
A positive correlation was found between the division
index of cells and [3H]thymidine incorporation (r = 0.84;
P = 0.001), as well as between the percentage of divided
cells and [3H]thymidine incorporation (r = 0.78; P = 0.004)
(Figure 1).
4. Discussion
This study determined the parameters to quantify the cell
proliferation of PBMC from patients infected with HTLV-1
by ﬂow cytometry. The results obtained indicated that
there was a strong correlation between the intensity of
spontaneous proliferation measured by the cell surface stain
CFSE and the [3H]thymidine incorporation assay. The cell
division index (average number of cell divisions) showed a
better correlation than percentage of divided cells, since it
may determine more accurately the number of cell divisions
occurring during culture [17].
Furthermore, using ﬂow cytometry it was possible to
quantify spontaneous proliferation in the ﬁrst 24 hours of
culture, compared with [3H]thymidine incorporation assay,
which requires three to four days of culture. The intensity
of proliferation remained stable over a culture period of
120 hours. Sixty-two percent of the individuals infected
with HTLV-1 had spontaneous proliferation of PBMCs. This
proportion was similar to that found by other authors using
the [3H]thymidine incorporation assay, which described
that 50% to 67% of individuals infected with HTLV-1 has
spontaneous proliferation of PBMC [6, 8]. The spontaneous
proliferation is one of the most important immunological
characteristics of the HTLV-1 infection.
Moreover, the proliferation of CD4+ and CD8+ T-lym-
phocyte subsets was quantiﬁed. Both CD4+ and CD8+ T-
lymphocyte subsets of infected individuals spontaneously
proliferate in culture, without any addition of exogenous
antigens or supplementary cytokines, such as IL-2. This
proliferation is also observed in vivo, and the proliferation
rate of the memory CD4+ T cells (CD45RO+)h a sb e e n
estimated in around 3% per day [7].
Comparedwith[3H]thymidineincorporationassay,clas-
sically used to evaluate proliferation in the context of the
HTLV-1 infection, the assay using cell staining with CFSE
provided a greater number of parameters for statistical
analysis is less laborious and expensive process and safer,
since it does not require the use of radioactive substances
[20–24]. This might be useful to study the pathogenesis of
HTLV-1-associated diseases or to evaluate the capacity ofISRN Oncology 5
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Figure 3: Flow cytometry proﬁles for evaluation of spontaneous proliferation of PBMCs by CFSE and analyzed by FlowJo software. (a)
PBMCs selected for analysis. (b) Unstained cells. (c) An example of curves generated by CFSE-stained PBMC representing cells does not
proliferate. (d) An example of curves generated by CFSE-stained PBMC represents proliferation. Each peak represents a cycle cell division.
The curves generated by the CFSE proﬁle were analyzed using the proliferation platform of the FlowJo software.
drugs to inhibit this process of spontaneous cell proliferation
of PBMC from HTLV-1-infected individuals.
5. Conclusions
The spontaneous proliferation of PBMC is assessable using
ﬂow cytometry. This method may prove useful to better
understandthephenomenonofspontaneousproliferationof
PBMC of patients infected with HTLV-1.
Conﬂict of Interests
The authors declare that there is no conﬂict of interests.
Acknowledgments
This work was supported by Oswaldo Cruz Foundation
(FIOCRUZ/PAPES V) and Brazilian National Research
Council (CNPq).
References
[1] Y. Hinuma, K. Nagata, M. Hanaoka et al., “Adult T-cell
leukemia: antigen in an ATL cell line and detection of
antibodies to the antigen in human sera,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 78, no. 10, pp. 6476–6480, 1981.
[2] A. Gessain, F. Barin, and J. C. Vernant, “Antibodies to hu-
man T-lymphotropic virus type-I in patients with tropical6 ISRN Oncology
spastic paraparesis,” The Lancet, vol. 2, no. 8452, pp. 407–410,
1985.
[ 3 ]M .O s a m e ,K .U s u k u ,S .I z u m oe ta l . ,“ H T L V - Ia s s o c i a t e d
myelopathy, a new clinical entity,” The Lancet, vol. 1, no. 8488,
pp. 1031–1032, 1986.
[4] M. Mochizuki, K. Yamaguchi, K. Takatsuki, T. Watanabe, S.
Mori, and K. Tajima, “HTLV-I and uveitis,” The Lancet, vol.
339, no. 8801, p. 1110, 1992.
[5] L. LaGrenade, B. Hanchard, V. Fletcher, B. Cranston, and W.
Blattner, “Infective dermatitis of Jamaican children: a marker
for HTLV-I infection,” The Lancet, vol. 336, no. 8727, pp.
1345–1347, 1990.
[6] R. E. Mascarenhas, C. Brodskyn, G. Barbosa et al., “Peripheral
blood mononuclear cells from individuals infected with hu-
man T-cell lymphotropic virus type 1 have a reduced capacity
to respond to recall antigens,” Clinical and Vaccine Immunol-
ogy, vol. 13, no. 5, pp. 547–552, 2006.
[7] B. Asquith, Y. Zhang, A. J. Mosley et al., “In vivo T lym-
phocyte dynamics in humans and the impact of human T-
lymphotropic virus 1 infection,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 104,
no. 19, pp. 8035–8040, 2007.
[8] H. E. Prince, H. Lee, E. R. Jensen et al., “Immunologic cor-
relates of spontaneous lymphocyte proliferation in human T-
lymphotropic virus infection,” Blood, vol. 78, no. 1, pp. 169–
174, 1991.
[9] M. Popovic, G. Lange Wantzin, P. S. Sarin, D. Mann, and R. C.
Gallo, “Transformation of human umbilical cord blood T cells
byhumanT-cellleukemia/lymphomavirus,”Proceedingsofthe
National Academy of Sciences of the United States of America,
vol. 80, no. 17 I, pp. 5402–5406, 1983.
[10] A. Kr¨ amer, S. Jacobson, J. F. Reuben et al., “Spontaneous
lymphocyte proliferation in symptom-free HTLV-I positive
Jamaicans,” The Lancet, vol. 2, no. 8668, pp. 923–924, 1989.
[11] C. R. Bangham and M. Osame, “Cellular immune response to
HTLV-1,” Oncogene, vol. 24, no. 39, pp. 6035–6046, 2005.
[12] J. C. Vernant, L. Maurs, A. Gessain et al., “Endemic tropical
spastic paraparesis associated with human T-lymphotropic
virus type I: a clinical and seroepidemiological study of 25
cases,” Annals of Neurology, vol. 21, no. 2, pp. 123–130, 1987.
[13] M. Yoshida, J. Inoue, J. Fujisawa, and M. Seiki, “Molecular
mechanisms of regulation of HTLV-1 gene expression and its
association with leukemogenesis,” Genome,v o l .3 1 ,n o .2 ,p p .
662–667, 1989.
[14] A. Gessain, F. Saal, O. Gout et al., “High human T-cell
lymphotropic virus type I proviral DNA load with polyclonal
integration in peripheral blood mononuclear cells of French
West Indian, Guianese, and African patients with tropical
spastic paraparesis,” Blood, vol. 75, no. 2, pp. 428–433, 1990.
[15] S. Olindo, A. L´ ezin, P. Cabre et al., “HTLV-1 proviral load
in peripheral blood mononuclear cells quantiﬁed in 100
HAM/TSP patients: a marker of disease progression,” Journal
of the Neurological Sciences, vol. 237, no. 1-2, pp. 53–59, 2005.
[16] M. Nagai, K. Usuku, W. Matsumoto et al., “Analysis of HTLV-I
proviralloadin202HAM/TSPpatientsand243asymptomatic
HTLV-I carriers: high proviral load strongly predisposes to
HAM/TSP,” Journal of NeuroVirology, vol. 4, no. 6, pp. 586–
593, 1998.
[17] R. Angulo and D. A. Fulcher, “Measurement of Candida-
speciﬁc blastogenesis: comparison of carboxyﬂuorescein suc-
cinimidyl ester labelling of T cells, thymidine incorporation,
and CD69 expression,”Communications inClinical Cytometry,
vol. 34, no. 3, pp. 143–151, 1998.
[18] S. I. Mannering, J. S. Morris, K. P. Jensen et al., “A sensitive
method for detecting proliferation of rare autoantigen- spe-
ciﬁc human T cells,” Journal of Immunological Methods, vol.
283, no. 1-2, pp. 173–183, 2003.
[19] K. Venken, M. Thewissen, N. Hellings et al., “A CFSE based
assay for measuring CD4+CD25+ regulatory T cell mediated
suppression of auto-antigen speciﬁc and polyclonal T cell
responses,” Journal of Immunological Methods, vol. 322, no. 1-
2, pp. 1–11, 2007.
[20] S. L. Welles, N. Tachibana, A. Okayama et al., “Decreased
reactivity to PPD among HTLV-I carriers in relation to virus
and hematologic status,” International Journal of Cancer, vol.
56, no. 3, pp. 337–340, 1994.
[21] J. Hasbold, A. V. Gett, J. S. Rush et al., “Quantitative analysis
of lymphocyte diﬀerentiation and proliferation in vitro using
carboxyﬂuorescein diacetate succinimidyl ester,” Immunology
and Cell Biology, vol. 77, no. 6, pp. 516–522, 1999.
[ 2 2 ]A .L .G i v a n ,J .L .F i s h e r ,M .G .W a u g h ,N .B e r c o v i c i ,a n dP .K .
Wallace, “Use of cell-tracking dyes to determine proliferation
precursor frequencies of antigen-speciﬁc T cells,” Flow Cytom-
etry Protocols, vol. 263, pp. 109–124, 2004.
[23] A. V. Gett and P. D. Hodgkin, “A cellular calculus for signal
integration by T cells,” Nature Immunology,v o l .1 ,n o .3 ,p p .
239–244, 2000.
[24] D. Liu, J. Yu, H. Chen, R. Reichman, H. Wu, and X. Jin,
“Statistical determination of threshold for cellular division in
the CFSE-labeling assay,” Journal of Immunological Methods,
vol. 312, no. 1-2, pp. 126–136, 2006.